Metropolitan Life Insurance Company (MetLife)’s Calithera Biosciences, Inc CALA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-936	Closed	-$91.9K	–	2611
2020 Q4	$91.9K	Sell	936 -15	-2%	-$1.31K	﹤0.01%	2394
2020 Q3	$65.6K	Sell	951 -146	-13%	-$12.7K	﹤0.01%	2426
2020 Q2	$116K	Buy	1,097 +289	+36%	+$34.3K	﹤0.01%	2160
2020 Q1	$71.7K	Buy	+808	New	+$96.3K	﹤0.01%	2242

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CALA Position: Q1 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 936 shares — an estimated $91.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CALA in Q1 2020 and held it in 4 quarters. The position peaked at $116K in Q2 2020. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 936 Calithera Biosciences, Inc shares in Q1 2021, an estimated $91.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Calithera Biosciences, Inc in Q1 2020 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Calithera Biosciences, Inc position peaked at $116K in Q2 2020.
100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2021, filed 14 May 2021.